Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation

Clinical and Experimental Hypertension

Volumn 30, Issue 2, 2008, Pages 133-141

  Elias, Gracieli P ^a   Sassaki, Kikue T ^a   Delbem, Alberto C B ^a   Antoniali, Cristina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Atenolol; Salivary glands; Spontaneously hypertensive rats (SHR)

Indexed keywords

AMYLASE; ATENOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEALTH; HYPERTENSION; LACTATION; MALE; NONHUMAN; PREGNANCY; RAT; SALIVARY GLAND; SALIVATION;

ADRENERGIC BETA-ANTAGONISTS; AMYLASES; ANIMALS; ATENOLOL; FEMALE; HYPERTENSION; LACTATION; MALE; ORGAN SIZE; OSMOLAR CONCENTRATION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RATS; RATS, INBRED SHR; RATS, WISTAR; SALIVA; SALIVARY GLANDS; SALIVARY PROTEINS;

EID: 39749168317     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960801931923     Document Type: Article

References (34)

1. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: Trends in prevalence, incidence and control. Annu Rev Public Health. 2006;27:465-490.
2. Vasconcellos MJA, Almeida MVL, Kahhale S, Peraçoli JC, Sass N, Ramos JG. Hipertensão na gravidez: Projeto Diretrizes. Available at http://www.projetodiretrizes.org.br/projeto_diretrizes/061.pdf Accessed: 29 September 2006.
3. Barton JR, Witlin AG, Sibai BM. Management of mild preeclampsia. Clin Obstet Gynecol. 1999;42(3):455.
4. Haddad B, Sibai BM. Chronic hypertension in pregnancy. Ann Med. 1999;31(4):246-252.
5. Zhang YC, Bui JD, Shen L, Phillips MI. Antisense inhibition of beta1-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats. Circulation. 2000;101(6):682-688.
6. Chung NAY, Beevers DG, Lipi GYH. Management of hypertension in pregnancy. Am J Cardiovasc Drugs. 2001;1(4):253-262.
7. Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev. 2004;12(4):201-221.
8. Tabacova S, Kimmel CA, Wall K, Hansen D. Atenolol developmental toxicity: animal-to-human comparisons. Birth Defects ResA Clin Mol Teratol. 2003;67:181-192.
9. Speiser Z, Gordon I, Rehavi M, Gitter S. Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. Eur J Pharmacol. 1991;195:75-83.
10. Beal AM. Blockade of isoprenaline-induced fluid and protein secretion by the mandibular glands of the red kangaroo, Macropus rufus, with selective antagonists. Arch Oral Biol. 2000;45:701-706.
11. Psoter WJ, Reid BC, Katz RV. Malnutrition and dental caries: A review of the literature. Caries Res. 2005;39:441-447.
12. Bernarde MA, Fabian FW, Rosen S, Hoppert CA, Hunt HR. A method for collection of large quantities of rat saliva. J Dent Res. 1956; 35:326-327.
13. Lowry OH, Rosebrough NS, Farr AL, Randall, RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:275-282.
14. Hebert MF, Carr DB, Anderson GD, Blough D, Green GE, Brateng DA, et al. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol. 2005;45:25-33.
15. Pfeffer MA, Pfeffer JM, Weiss AK, Frohlich ED. Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade. Am J Physiol. 1977;232(6):H639-H644.
16. Pacca SRMC, Azevedo AP, Oliveira CF, De Luca IMS, De Nucci G, Antunes E. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by β-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. J Cardiovasc Pharmacol. 2002;39:201-207.
17. Easterling TR, Carr DB, Brateng B, Diederichs C, Schmucker B. Treatment of hypertension in pregnancy: Effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol. 2001;98:427-433.
18. Montán S. Drug used in hypertensive disease in pregnancy. Curr Opin Obstet Gynecol. 2004;16:111-115.
19. Sibai B, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med. 1998;339:667-671.
20. Kramer MS, Platt R, Yang H, McNamara H, Usher RH. Are all growth-restricted infants created equal? Pediatrics. 1999;103:599-602.
21. Wlodek ME, Westcott KT, Ho PW, Serruto A, Di Nicolantonio R, Farrugia W, et al. Reduced fetal, placental and amniotic fluid PTHRP in the growth-restricted spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol. 2000;279:R31-R38.
22. Elias GP, Santos OAM, Sassaki KT, Delbem ACB, Antoniali C. Dental mineralization and salivary activity are reduced in offspring of spontaneously hypertensive rats (SHR). Journal of Applied Oral Science. 2006;14(4):253-259.
23. Nederfors T, Dahlof C, Twetman S. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human unestimulated whole saliva flow rate and protein composition. Scand J Dent Res. 1994;102:235-237.
24. Nederfors T, Ericsson T, Twetman S, Dahlof C. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion. J Dent Res. 1994;73(1):5-10.
25. Parvinen T, Parvinen I, Larmas M. Stimulated salivary flow rate, pH and lactobacillus and yeast concentrations in medicated persons. Scand J Dent Res. 1984;92:524-532.
26. Streckfus CF, Welsh S, Strahl RC. Diminuition of parotid IgA secretion in an elderly black population taking antihypertension medication. Oral Surg Oral Med Oral Pathol. 1991;71:50-54.
27. Wu AJ, Ship JA. A characterization of major salivary gland flow rates in the presence of medications and systemic diseases. Oral Surg Oral Med Oral Pathol. 1993;76:301-306.
28. Schneyer CA, Yu JH, Jirakulsomchok D. Modification of dobutamine-and terbutaline-induced calcium and fluid secretion from rat salivary glands by atenolol and butoxamine. J Auton Nerv Syst. 1985;13:275-285.
29. Holloway PJ, Willians RAD. A study of the oral secretion of rats stimulated by pilocarpine. Arch Oral Biol. 1965;10:237-344.
30. Baum BJ. Neurotransmitter control of secretion. J Dent Res. 1987;66:628-632.
31. Diaz-Arnold AM, Marek CA. The impact of saliva on patient care: A literature review. J Prosthet Dent. 2002;88(3):337-343.
32. Mandel ID. The role of saliva in maintaining oral homeostasis. JADA. 1989;119:298-304.
33. Bardow A, Nyvad B, Nauntofte B. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol. 2001;46:413-423.
34. Fejerskov O, Kidd E. Cárie dentária: A doença e seu tratamento clínico. São Paulo: Santos; 2005.